On January 8, 2021, Brazil claimed that the effectiveness of China's Kexing vaccine was 78%, of which the effectiveness for moderate and severe diseases was as high as 100%. On January 19, the Serbian Bureau of Medicines and Medical Devices approved the use of the new crown produced by China National Pharmaceutical Group vaccine.